AHA Member Advisory
September 16, 2020
This week, the RAND Corporation is slated to release Round 3 of its National Hospital Price Transparency Study, an employer-led initiative intended to measure and report publicly the prices paid for care at the hospital and service-line level. While we have not yet been able to review the document, we expect RAND to continue to make broad claims about pricing based on a limited sample of private health plan rates in selected states. The new version also may include additional self-funded plans and quality data from the Leapfrog group.